Latest News
View all newsSelf-expanding TAVR valves from Medtronic, Abbott consistently linked to positive outcomes
Self-expanding TAVR valves from Medtronic and Abbott demonstrate consistent positive clinical outcomes in comparative analyses. The findings support the sustained performance profile of these platforms in transcatheter aortic valve replacement procedures.
Digest: These data reinforce operator confidence in self-expanding valve technology and may influence device selection strategies among interventional cardiologists, particularly in anatomies where self-expanding platforms offer theoretical advantages.
Abbott kicks off new research on software-guided, balloon-expandable TAVR system
Abbott has initiated new research on a software-guided, balloon-expandable transcatheter aortic valve replacement system. No specific clinical data or trial endpoints were provided in the article content.
Digest: Abbott's entry into balloon-expandable TAVR with software guidance could challenge Edwards and Medtronic's market dominance and potentially improve procedural precision and outcomes.

Device shows benefit in severe tricuspid regurgitation
The CLASP II TR trial randomized 450 patients with symptomatic severe tricuspid regurgitation to transcatheter tricuspid valve repair with the Pascal Precision system (Edwards Lifesciences) versus optimal medical therapy alone. At 1 year, the device improved health status and reduced TR severity compared with medical therapy, though no significant difference was observed in mortality or heart failure hospitalization.
Digest: This represents the first randomized controlled trial data for the FDA-approved Pascal Precision system in tricuspid regurgitation, providing evidence for transcatheter intervention in a valve position historically undertreated and associated with poor outcomes.
Abbott Begins Enrollment in Global Trial of Investigational Mitral Valve Replacement System
Abbott has initiated enrollment in a global clinical trial evaluating its investigational transcatheter mitral valve replacement system. No specific enrollment targets, trial design details, or timeline information were provided in the article.
Digest: This represents Abbott's strategic entry into the competitive TMVR market, currently dominated by early-stage investigational devices from Edwards and Medtronic.
GE HealthCare Introduces Ceiling-Mounted Image Guiding System
GE HealthCare has launched a ceiling-mounted image guiding system for interventional procedures. No specific clinical performance data or technical specifications were provided in the brief announcement.
Digest: Advanced imaging systems are critical infrastructure for structural heart interventions including TAVR and TMVR, potentially improving procedural visualization and workflow efficiency.

TAVR benefits high-risk patients with moderate aortic stenosis
The PROGRESS trial demonstrated that TAVR with a balloon-expandable valve reduced the risk of death or heart failure events at 2 years compared with clinical surveillance in high-risk patients with moderate aortic stenosis and at-risk features. The primary safety outcome at 30 days occurred in 5.9% of patients, meeting the performance goal, while the primary effectiveness outcome at 2 years occurred in 16.7% of the TAVR group.
Digest: This randomized trial challenges current practice by demonstrating clinical benefit of early intervention in moderate aortic stenosis, potentially expanding TAVR indications beyond severe disease in selected high-risk patients.

Deaths from heart valve disease rising among U.S. adults ages 65 and older
Valvular heart disease mortality among U.S. adults aged 65 and older increased nearly 5% from 2018 to 2023, reversing a two-decade decline. Death rates rose from 104 to 109 per 100,000, with highest impact among men, non-Hispanic white adults, adults 85 and older, and nonmetropolitan residents.
Digest: Rising VHD mortality despite advances in transcatheter therapies signals potential gaps in early detection and access to valve interventions in aging and rural populations, informing market opportunity and healthcare delivery strategies.
Top Publications
View all researchPCR London Valves
Nov 22-24, 2026
London, United Kingdom
Coming Up
Society of Thoracic Surgeons Annual Meeting
Jan 28-31, 2027 · New Orleans, LA
American College of Cardiology Scientific Session
Apr 10-12, 2027 · Houston, TX
EuroPCR
May 18-21, 2027 · Paris, France
New York Valves Structural Heart Summit
Jun 23-25, 2027 · New York, NY
Transcatheter Cardiovascular Therapeutics
Oct 18-21, 2027 · San Francisco, CA
Xinhua Hospital, Shanghai
EnCompass Technologies, I